Evidence map›Paper›PMID 31114365›Full record

ArticleCancer management and research2019

Oncolytic viro-chemotherapy exhibits antitumor effect in laryngeal squamous cell carcinoma cells and mouse xenografts.

Yigang Wang, Binrong Wang, Junnan Liang, Caixia Cui, Chang Ying, Fang Huang, Buyun Ma, Xiumei Zhou, Liang Chu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer management and research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Yigang WangCollege of Life Sciences, Zhejiang Sci-Tech University, Hangzhou 310018, People's Republic of China.
Binrong WangCollege of Life Sciences, Zhejiang Sci-Tech University, Hangzhou 310018, People's Republic of China.
Junnan LiangHepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People's Republic of China.
Caixia CuiDepartment of Otorhinolaryngology, Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, People's Republic of China.
Chang YingCollege of Life Sciences, Zhejiang Sci-Tech University, Hangzhou 310018, People's Republic of China.
Fang HuangDepartment of Pathology, Zhejiang Provincal People's Hospital, Hangzhou 310014, People's Republic of China.
Buyun MaCollege of Life Sciences, Zhejiang Sci-Tech University, Hangzhou 310018, People's Republic of China.
Xiumei ZhouCollege of Life Sciences, Zhejiang Sci-Tech University, Hangzhou 310018, People's Republic of China.
Liang ChuHepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People's Republic of China.
Zhejiang Sci-Tech University · CNTongji Hospital · CNAffiliated Hospital of Hangzhou Normal University · CNZhejiang Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

doxorubicinlaryngocarcinomaoncolytic virusZD55-TRAIL

Identifiers

PMID31114365
PMCPMC6489678
OpenAlexW2938854367

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.